Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
This study is currently recruiting participants.
Verified April 2013 by Fresenius Biotech GmbH
Sponsor:
Fresenius Biotech GmbH
Collaborator:
Fresenius Biotech North America
Information provided by (Responsible Party):
Fresenius Biotech GmbH
ClinicalTrials.gov Identifier:
NCT01295710
First received: February 9, 2011
Last updated: April 12, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2015 |
| Estimated Primary Completion Date: | June 2015 (Final data collection date for primary outcome measure) |